The U.S. Food and Drug Administration (FDA) announced the final revised guidance titled “Clinical Performance Assessment: Considerations for Computer Assisted Detection Devices Applied to Radiology Images and Radiology Device Data in Premarket Notification (510(k))”(referred to as the “FDA Guidance” below) in September 2022. This issue offers insights in Chinese on key aspects of the FDA Guidance that are particularly important for formulating the clinical trial design of Computer Assisted Detection (CADe) systems.
Category
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.